STING1 and cancer: Lipopolysaccharide (LPS), cytosine-phosphate-guanosine oligodeoxynucleotides (CpG-ODN), agonists of stimulator of interferon genes (STING), and polyinosinic-polycytidylic acid (poly I:C) are commonly used adjuvants in cancer immunotherapy [58].